Main menu

Unlocking the biopharma development pipeline with Oxford Nanopore


Introductory guide: biopharma — 2 pages

Overview

The current drug development process can be long, complex, and resource-intensive. One major bottleneck is the use of a compendium of conventional assays and analytical tools, which have inherent limitations that restrict efficiency, accuracy, scalability, and fast decision-making.

In this introductory guide, discover how a new generation of molecular sensing technology from Oxford Nanopore is transforming the biopharma development pipeline. Oxford Nanopore sequencing is a single-platform solution that is streamlining the process from discovery to clinical development:

  • Novel biomarker discovery and target identification
  • Candidate identification
  • Construct characterisation
  • Expression optimisation
  • Viral vector characterisation
  • Cell line development
  • Quality control release testing
  • Clinical development and post-market surveillance

Download

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag